Just having a think about the low valuation and high growth runway points you mentioned.
At a $50m market cap this is indeed being valued absurdly low. Even for a pre-revenue speculative company in distress, $50m would still look low.
From a numbers perspective, buying shares whilst this is at a $50m market cap means:
- 10x upside at a market cap of only $500m ($2.60 share price)
- 20x upside at a market cap of only $1 billion ($5.30 share price)
- 100x upside at a market cap of $5 billion ($26.30 share price)
- 200x upside at a market cap of $10 billion ($52.60 share price)
Those are all fairly realistic targets. If this were US listed, $10 billion would in fact look quite conservative. If 2RT is indeed FDA approved, that could very well make a $10b market cap look very cheap. But even if it isn’t, iTrack Advance alone could probably get this valued in the billions once the market decides to wake up! Lots of quality growth stocks like EYE out there, but most are already valued above $500 million and so the upside is usually capped at a max of 10x, which of course is still fantastic. However EYE really does have a tremendous amount of room to run, especially if they can keep coming up with new and innovative products.
I think I’ve made myself want to buy some more shares on Monday!
- Forums
- ASX - By Stock
- EYE
- Nova Eye (EYE) Summary 31 Dec 2023
Nova Eye (EYE) Summary 31 Dec 2023, page-14
-
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $52.68M |
Open | High | Low | Value | Volume |
23.0¢ | 23.0¢ | 22.5¢ | $6.366K | 28.16K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 125015 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 16381 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 125015 | 0.225 |
3 | 114413 | 0.220 |
3 | 98000 | 0.215 |
11 | 299185 | 0.210 |
5 | 66036 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 16381 | 4 |
0.235 | 101849 | 3 |
0.245 | 12081 | 1 |
0.250 | 200000 | 3 |
0.255 | 125000 | 2 |
Last trade - 12.26pm 15/08/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online